Grant of Options

Summary by AI BETAClose X

Hercules PLC has granted options to subscribe for 1,275,000 ordinary shares at an exercise price of 34.5 pence each, reflecting the closing price on October 1, 2026. These options are exercisable between October 2, 2029, and October 2, 2031, and were issued to certain employees of the company.

Disclaimer*

Hercules PLC
02 October 2026
 

2 October 2026

Hercules plc

 

(“Hercules” or the “Company”)

 

Grant of Options

Hercules (AIM: HERC), a leading UK power and infrastructure services group, announces that options (“Options”) to subscribe for a total of 1,275,000 ordinary shares of 0.1 pence each in the Company (“Ordinary Shares”) were granted on 2 October to certain employees of the Company.

The Options vest on 2 October 2029 and have an exercise price of 34.5 pence each, being the closing price on 1 October 2026, and are exercisable over the following two years to 2 October 2031.

 

For further information and enquiries, please contact:

 

Hercules plc

Brusk Korkmaz (CEO)

Paul Wheatcroft (CFO)

                 c/o SEC Newgate

 

 

SP Angel Corporate Finance LLP

(Nominated Adviser and Broker)

Matthew Johnson / Adam Cowl (Corporate Finance)

Grant Barker / Rob Rees (Sales and Broking)

            +44 (0) 20 3470 0470

 

SEC Newgate (Financial Communications)

Elisabeth Cowell / Ian Silvera / Darcy Dubell

           +44 (0) 20 3757 6882

Hercules@secnewgate.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100